Hiroo Makimoto
- Molecular Biology
- Oncology
- Geriatrics and Gerontology top 10%
- Cancer Research
- Pulmonary and Respiratory Medicine
- Co-authors
- Tadanori MayumiNaoki UtoguchiMidori HiraiKazuhiro YamamotoManabu KumeAtsushi UdaTatsuya NishiokaShinsaku Nakagawa
- Topics
- Angiogenesis and VEGF in Cancer (8 papers)Pharmacy and Medical Practices (7 papers)Pharmaceutical Practices and Patient Outcomes (6 papers)
- Partner nations
- JapanUnited States
In The Last Decade
Hiroo Makimoto
30 papers receiving 338 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 161
- Oncology 90
- Geriatrics and Gerontology 52
- Cancer Research 49
- Pulmonary and Respiratory Medicine 42
Countries citing papers authored by Hiroo Makimoto
This map shows the geographic impact of Hiroo Makimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroo Makimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroo Makimoto more than expected).
Fields of papers citing papers by Hiroo Makimoto
This network shows the impact of papers produced by Hiroo Makimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroo Makimoto. The network helps show where Hiroo Makimoto may publish in the future.
Co-authorship network of co-authors of Hiroo Makimoto
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroo Makimoto. A scholar is included among the top collaborators of Hiroo Makimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroo Makimoto. Hiroo Makimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 8 | |
| 6 | 11 | |
| 7 | 27 | |
| 8 | 1 | |
| 9 | 16 | |
| 10 | 22 | |
| 11 | 6 | |
| 12 | 14 | |
| 13 | 12 | |
| 14 | 24 | |
| 15 | 7 | |
| 16 | 7 | |
| 17 | 13 | |
| 18 | 9 | |
| 19 | 27 | |
| 20 | 12 |
About Hiroo Makimoto
Hiroo Makimoto is a scholar working on Geriatrics and Gerontology, Pharmacology and Toxicology, having authored 32 papers that have together received 346 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (8 papers), Pharmacy and Medical Practices (7 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). The work is most often cited by research in Geriatrics and Gerontology (52 citations), Family Practice (16 citations) and Immunology and Allergy (40 citations). Hiroo Makimoto has collaborated with scholars based in Japan and United States. Frequent co-authors include Tadanori Mayumi, Naoki Utoguchi, Midori Hirai, Kazuhiro Yamamoto, Manabu Kume, Atsushi Uda, Tatsuya Nishioka, Shinsaku Nakagawa, Yasuo Tsutsumi and Takeshi Hirano. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.